Bioresorbable Coronary Scaffolds Market delivers detailed overview of the bioresorbable coronary scaffolds market in terms of market segmentation by material, by product, by application, by end user and by region.
Bioresorbable coronary scaffolds are the devices that are bodily-absorbable and are widely used in the treatment of CVDs to prevent blood flow challenges. Owing to its re-absorbability into the body and applications in various cardio-vascular diseases, the global bioresorbable coronary scaffolds market is anticipated to record a significant CAGR over the forecast period, i.e., 2020-2028.
Get Free Sample Copy of this Report @: https://www.researchnester.com/sample-request-1110
The global bioresorbable coronary scaffolds market is segmented into five major regions including North America, Europe, Asia Pacific, Latin America and Middle East & Africa region. Among these regions, the market in North America is predicted to hold the leading share in the market on account of presence of leading market players in the region which manufacture and market bioresorbable coronary scaffolds. Additionally, the prevalence of CVDs and obesity in children in the region increases the product demand. The fast rate of ageing population in Asia Pacific is expected to drive the market growth in the region.
Major players include in the global Bioresorbable Coronary Scaffolds Market market:
- Abbott
- Elixir Medical Corporation
- Medtronic
- KYOTO MEDICAL PLANNING Co.,Ltd.
- Cardinal Health
- Boston Scientific Corporation or its affiliates
- Lombard Medical
- B. Braun Melsungen AG
- Terumo Corporation
Prevalence of CVDs and Technological advancements to Boost the Market Growth
The demand for bioresorbable coronary scaffolds is high owing to the rising inclination towards bodily-absorbable stents which is driven by technological advancements towards discovery of absorbable materials and superior scaffold performance. Additionally, various authoritative bodies across the world are prescribing these stents and raising awareness related to adopting these solutions in an attempt to curb the ill effects of CVDs post treatment. According to the WHO (World Health Organization), CVDs are the number 1 cause of deaths globally. IHME reported over 17 million deaths caused by CVDs in 2017 and the prevalence of CVDs is expected to grow among ageing population. Such factors are anticipated to significantly drive the market growth. However, high cost of these bioresorbable stents is estimated to hamper the market growth.
This report also provides the existing competitive scenario of some of the key players of the global Bioresorbable Coronary Scaffolds market which includes company profiling of BIOTRONIK, Abbott, Elixir Medical Corporation, Medtronic, KYOTO MEDICAL PLANNING Co., LTD., Cardinal Health, Boston Scientific Corporation or its affiliates, Lombard Medical, B. Braun Melsungen AG, Terumo Corporation.
Buy a Copy of this Strategic Report to drive your Business Growth @ https://www.researchnester.com/reports/bioresorbable-coronary-scaffolds-market/1110
Research Nester is a leading service provider for strategic market research and consulting. We aim to provide unbiased, unparalleled market insights and industry analysis to help industries, conglomerates and executives to take wise decisions for their future marketing strategy, expansion and investment etc. We believe every business can expand to its new horizon, provided a right guidance at a right time is available through strategic minds. Our out of box thinking helps our clients to take wise decision in order to avoid future uncertainties.
Contact for more Info:
AJ Daniel
Email: info@researchnester.com
U.S. Phone: +1 646 586 9123
U.K. Phone: +44 203 608 5919